Skip to content

Assessment of the function of the telemedicine device

Assessment of the function of the telemedicine device in order to report lead 2 of electrocardiogram, heart rate, body temperature, peripheral pulse rate and the level of blood oxygen

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230808059080N1
Enrollment
80
Registered
2023-08-14
Start date
2023-08-12
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Atrial fibrillation and atrial flutter (AF). Condition 2: Ventricular tachycardia (VT). Condition 3: Paroxysmal supraventricular tachycardia (PSVT). Condition 4: Premature ventricular contractions (PVC). Condition 5: Premature atrial contractions (PAC). Condition 6: Atrial tachycardia (AT). Unspecified atrial fibrillation and atrial flutter Ventricular tachycardia Supraventricular tachycardia (paroxysmal) Ventricular premature depolarization Atrial premature depolarization Sup

Interventions

Intervention 1: Intervention group: The patients who have at least one of the 6 types of common cardiac arrhythmias diagnosed by the cardiologist and the telemedicine device manufactured in Behbood Sa

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years and over Refer to the cardiology clinic for check-up or cardiological treatment

Exclusion criteria

Exclusion criteria: The patient´s inability to use the telemedicine device Not to provide consent to participate in the study by the patient

Design outcomes

Primary

MeasureTime frame
Lead 2 of the electrocardiogram. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.;Body temperature. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.;The level of blood oxygen. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement wil

Secondary

MeasureTime frame
Acceptance of the device by the patient. Timepoint: At the end of the intervention. Method of measurement: By asking a question about the patient's satisfaction with the device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFazel Tarkhan

Babol University of Medical Sciences

medslums@gmail.com+98 11 3219 7667

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026